These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 23044640
1. Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years. Lyseng-Williamson KA. Drugs Aging; 2012 Nov; 29(11):911-23. PubMed ID: 23044640 [Abstract] [Full Text] [Related]
2. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Otmani S, Demazières A, Staner C, Jacob N, Nir T, Zisapel N, Staner L. Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235 [Abstract] [Full Text] [Related]
3. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. Lemoine P, Nir T, Laudon M, Zisapel N. J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082 [Abstract] [Full Text] [Related]
4. [Controlled release melatonin (Circadin) in the treatment of insomnia in older patients: efficacy and safety in patients with history of use and non-use of hypnotic drugs]. Zisapel N. Harefuah; 2009 May; 148(5):337-41, 348. PubMed ID: 19630367 [Abstract] [Full Text] [Related]
5. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N. Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243 [Abstract] [Full Text] [Related]
6. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. Wade AG, Ford I, Crawford G, McConnachie A, Nir T, Laudon M, Zisapel N. BMC Med; 2010 Aug 16; 8():51. PubMed ID: 20712869 [Abstract] [Full Text] [Related]
7. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin®) in insomnia]. Quera-Salva MA, Claustrat B. Encephale; 2018 Dec 16; 44(6):548-557. PubMed ID: 30107892 [Abstract] [Full Text] [Related]
8. Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia. Lemoine P, Zisapel N. Expert Opin Pharmacother; 2012 Apr 16; 13(6):895-905. PubMed ID: 22429105 [Abstract] [Full Text] [Related]
9. Lasting treatment effects in a postmarketing surveillance study of prolonged-release melatonin. Hajak G, Lemme K, Zisapel N. Int Clin Psychopharmacol; 2015 Jan 16; 30(1):36-42. PubMed ID: 25054634 [Abstract] [Full Text] [Related]
10. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response. Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N. Curr Med Res Opin; 2011 Jan 16; 27(1):87-98. PubMed ID: 21091391 [Abstract] [Full Text] [Related]
11. Prolonged-release melatonin for the treatment of insomnia in patients over 55 years. Wade A, Downie S. Expert Opin Investig Drugs; 2008 Oct 16; 17(10):1567-72. PubMed ID: 18808316 [Abstract] [Full Text] [Related]
12. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder. Maras A, Schroder CM, Malow BA, Findling RL, Breddy J, Nir T, Shahmoon S, Zisapel N, Gringras P. J Child Adolesc Psychopharmacol; 2018 Dec 16; 28(10):699-710. PubMed ID: 30132686 [Abstract] [Full Text] [Related]
13. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T, ZOLONG Study Group. Sleep; 2008 Jan 16; 31(1):79-90. PubMed ID: 18220081 [Abstract] [Full Text] [Related]
14. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder. Gringras P, Nir T, Breddy J, Frydman-Marom A, Findling RL. J Am Acad Child Adolesc Psychiatry; 2017 Nov 16; 56(11):948-957.e4. PubMed ID: 29096777 [Abstract] [Full Text] [Related]
15. [Melatonin for children with insomnia]. Berring-Uldum A, Debes NMM, Pedersen CR, Holst H. Ugeskr Laeger; 2018 May 07; 180(19):. PubMed ID: 29761771 [Abstract] [Full Text] [Related]
16. Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia. Lähteenmäki R, Neuvonen PJ, Puustinen J, Vahlberg T, Partinen M, Räihä I, Kivelä SL. Basic Clin Pharmacol Toxicol; 2019 Mar 07; 124(3):330-340. PubMed ID: 30295409 [Abstract] [Full Text] [Related]
17. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. Ancoli-Israel S, Krystal AD, McCall WV, Schaefer K, Wilson A, Claus R, Rubens R, Roth T. Sleep; 2010 Feb 07; 33(2):225-34. PubMed ID: 20175406 [Abstract] [Full Text] [Related]
18. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T. J Clin Psychiatry; 2011 Jul 07; 72(7):914-28. PubMed ID: 21208597 [Abstract] [Full Text] [Related]
19. Melatonin in medically ill patients with insomnia: a double-blind, placebo-controlled study. Andrade C, Srihari BS, Reddy KP, Chandramma L. J Clin Psychiatry; 2001 Jan 07; 62(1):41-5. PubMed ID: 11235927 [Abstract] [Full Text] [Related]
20. Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT. van Geijlswijk IM, van der Heijden KB, Egberts AC, Korzilius HP, Smits MG. Psychopharmacology (Berl); 2010 Oct 07; 212(3):379-91. PubMed ID: 20668840 [Abstract] [Full Text] [Related] Page: [Next] [New Search]